市場調查報告書
商品編碼
1503350
2030 年生物資訊市場預測:按產品、應用、最終用戶和地區進行的全球分析Bioinformatics Market Forecasts to 2030 - Global Analysis By Product (Bioinformatics Platforms, Bioinformatics Services and Other Products), Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球生物資訊學市場規模將達133億美元,預計2030年將達到308億美元,預測期內複合年成長率為15.0%。
生物資訊學是結合生物學、電腦科學和資訊技術來分析和解釋生物資料的跨學科領域。它涉及開發演算法、軟體工具和資料庫來儲存、管理和分析大量生物資料,如 DNA 序列、蛋白質結構和基因表現。生物資訊學在生物研究的各個領域發揮著重要作用,包括基因組學、蛋白質組學、演化生物學和藥物發現。透過利用計算和統計技術,生物資訊學使研究人員能夠深入了解生物過程,了解疾病機制,開發新的治療方法,並最終加深對科學和醫學的理解。
根據史丹佛醫學2022年1月發表的報導稱,史丹佛大學科學家進行的研究表明,DNA序列測定技術可以在大約8小時內對人類基因組序列測定。
對次世代定序儀(NGS) 的需求迅速成長,資料量不斷增加
次世代定序儀產生大量複雜資料,包括 DNA 和蛋白質序列。如果沒有適當的分析和解釋,這些資料本質上就毫無意義。生物資訊工具對於理解這些資料、識別模式和得出有價值的見解至關重要。此外,雲端處理為儲存和分析 NGS資料提供了可擴展且經濟高效的解決方案。這種雲端基礎的生物資訊學工具的成長正在進一步擴大市場,並使這些強大的資源更容易獲得,從而推動市場成長。
生物資訊學工具和服務高成本
這些工具的複雜性,加上分析資料所需的運算資源,導致其價格飆升。因此,預算有限的小型研究機構、學術實驗室和生物技術新興企業面臨著獲取和利用先進生物資訊解決方案的挑戰。這種獲取機會的差異可能會限制該領域不同相關人員的參與並阻礙市場成長,從而阻礙協作研究、創新和科學進步。
精準醫療和個人化醫療保健的興起
個人化醫療保健方法需要對個人遺傳、分子和臨床資料進行詳細分析,以便根據患者的獨特特徵和需求量身定做治療方案。生物資訊學在大型生物和醫學資料集的處理、分析和解釋中發揮核心作用,能夠識別生物標記、疾病亞型和治療標靶。隨著精準醫療在腫瘤學、循環系統和神經病學等各個醫學領域變得普及,對先進生物資訊學工具和服務的需求呈指數級成長。
缺乏熟練的生物資訊學專業人員
隨著對生物資訊工具和服務的需求增加,對計算生物學、資料分析和程式設計專家的需求也在增加。然而,該專業合格專業人員的供應往往低於行業需求。這種不足可能會延遲研究計劃,降低資料分析的效率,並增加尋求利用生物資訊解決方案的組織的成本。
COVID-19 的影響
由於迫切需要了解病毒的基因組結構、感染模式和藥物開發,因此生物資訊學工具和專業知識至關重要。這增加了對分析 COVID-19 相關資料的生物資訊解決方案的需求,例如基因組序列測定、蛋白質建模和流行病學研究。此外,大流行期間研究活動的中斷和資金籌措挑戰影響了非新冠研究領域中生物資訊工具的採用。
分子系統發育部分預計在預測期內將是最大的
分子系統發育學預計將在預測期內達到最大規模,因為它嚴重依賴生物資訊工具和演算法來進行 DNA 和蛋白質序列分析、系統發育樹建構和演化建模。隨著分子系統學在進化生物學、生物多樣性保護和感染疾病研究等各種科學領域中發揮重要作用,對先進生物資訊解決方案的需求持續成長。
動植物生物技術領域預計在預測期內複合年成長率最高。
由於農業、製藥和環境保護領域擴大採用生物技術方法,動植物生物技術產業將在預測期內繼續成長,預計對專門用於動植物性因組資料分析的生物資訊解決方案的需求將會增加。這一趨勢正在刺激生物資訊軟體、資料庫和演算法的創新,旨在支持動植物生物技術研究和應用,刺激市場成長。
預計北美在預測期內將佔據最大的市場佔有率,因為該地區對生物資訊學工具和服務的需求很高,重點關注精準醫療、個人化醫療和基因組研究。技術進步、政府措施以及學術界和工業界之間的戰略合作等關鍵因素正在進一步推動市場成長。此外,製藥和生物技術公司擴大採用生物資訊學也有助於市場擴張。
由於增加醫療基礎設施投資、增加先進技術的採用以及擴大生命科學領域的研發活動等因素,亞太地區預計在預測期內將保持最高的複合年成長率。中國、印度、日本和韓國等國家在基因組學、蛋白質組學和個人化醫療方面取得了重大進展,推動了對生物資訊解決方案的需求。此外,該地區製藥和生物技術行業的快速成長也促進了生物資訊學工具和服務的日益採用。
According to Stratistics MRC, the Global Bioinformatics Market is accounted for $13.3 billion in 2024 and is expected to reach $30.8 billion by 2030 growing at a CAGR of 15.0% during the forecast period. Bioinformatics is an interdisciplinary field that combines biology, computer science, and information technology to analyze and interpret biological data. It involves developing algorithms, software tools, and databases to store, manage, and analyze large volumes of biological data, such as DNA sequences, protein structures, and gene expressions. Bioinformatics plays a crucial role in various areas of biological research, including genomics, proteomics, evolutionary biology, and drug discovery. By leveraging computational techniques and statistical methods, bioinformatics enables researchers to gain insights into biological processes, understand disease mechanisms, and develop novel therapies, ultimately advancing understanding of life sciences and medicine.
According to an article published by Stanford Medicine in January 2022, research conducted by Stanford scientists showed that a DNA sequencing technique could sequence a human genome in about 8 hours.
Surging demand for next-generation sequencing (NGS) and growing data volume
Next-generation sequencing generates massive amounts of complex data, including DNA and protein sequences. This data is essentially meaningless without proper analysis and interpretation. Bioinformatics tools are essential for making sense of this data, identifying patterns, and extracting valuable insights. Moreover cloud computing offers a scalable and cost-effective solution for storing and analyzing NGS data. This growth in cloud-based bioinformatics tools further expands the market and makes these powerful resources more accessible driving the growth of the market.
High cost of bioinformatics tools and services
The sophisticated nature of these tools, coupled with the computational resources required for data analysis, contributes to their elevated pricing. As a result, smaller research institutions, academic labs, and biotech startups with limited budgets may face challenges accessing and utilizing advanced bioinformatics solutions. This disparity in access can hinder collaboration, innovation, and scientific progress, as it limits the participation of diverse stakeholders in the field hampering the market growth.
Rise of precision medicine and personalized healthcare
Personalized healthcare approaches require detailed analysis of individual genetic, molecular, and clinical data to tailor treatments to patients' specific characteristics and needs. Bioinformatics plays a central role in processing, analyzing, and interpreting large-scale biological and medical data sets, enabling the identification of biomarkers, disease subtypes, and therapeutic targets. As precision medicine gains traction in various medical fields, including oncology, cardiology, and neurology, the demand for advanced bioinformatics tools and services grows exponentially.
Shortage of skilled bioinformatics professionals
As the demand for bioinformatics tools and services increases, there is a parallel need for experts proficient in computational biology, data analysis, and programming. However, the supply of qualified professionals in this specialized field often falls short of industry demands. This shortage can result in delays in research projects, reduced efficiency in data analysis, and increased costs for organizations seeking to utilize bioinformatics solutions.
Covid-19 Impact
The urgent need for understanding the virus's genomic structure, transmission patterns, and drug development, bioinformatics tools and expertise became crucial. This led to increased demand for bioinformatics solutions for analyzing COVID-19-related data, such as genomic sequencing, protein modeling, and epidemiological studies. Additionally, disruptions in research activities and funding challenges during the pandemic affected the adoption of bioinformatics tools in non-COVID research areas.
The molecular phylogenetics segment is expected to be the largest during the forecast period
The molecular phylogenetics is expected to be the largest during the forecast period as it relies heavily on bioinformatics tools and algorithms for DNA and protein sequence analysis, phylogenetic tree construction, and evolutionary modeling. As molecular phylogenetics plays a crucial role in various scientific disciplines such as evolutionary biology, biodiversity conservation, and infectious disease research, the demand for advanced bioinformatics solutions continues to grow.
The animal & plant biotechnology segment is expected to have the highest CAGR during the forecast period
The animal & plant biotechnology segment is expected to have the highest CAGR during the forecast period owing to increasing adoption of biotechnological approaches in agriculture, pharmaceuticals, and environmental conservation fuels the need for bioinformatics solutions tailored to animal and plant genomic data analysis. This trend stimulates market growth by spurring innovation in bioinformatics software, databases, and algorithms designed to support animal and plant biotechnology research and applications, thereby expanding opportunities and driving advancements in the bioinformatics market.
North America is projected to hold the largest market share during the forecast period due to a focus on precision medicine, personalized healthcare, and genomic research, the region witnesses' high demand for bioinformatics tools and services. Key factors such as technological advancements, government initiatives, and strategic collaborations between academia and industry further propel market growth. Additionally, the increasing adoption of bioinformatics in pharmaceutical and biotechnology companies contributes to the market's expansion.
Asia Pacific is projected to hold the highest CAGR over the forecast period due to factors such as increasing investments in healthcare infrastructure, rising adoption of advanced technologies, and expanding research and development activities in life sciences. Countries like China, India, Japan, and South Korea are witnessing significant advancements in genomics, proteomics, and personalized medicine, fueling demand for bioinformatics solutions. Additionally the region's burgeoning pharmaceutical and biotechnology sectors also contribute to the expanding adoption of bioinformatics tools and services.
Key players in the market
Some of the key players in Bioinformatics market include ABM, Agilent Technologies, BGI Group, Biowisdom Co., Ltd., Dassault Systemes, DNAnexus Inc., Fios Genomics, Geneva Bioinformatics SA, Illumina, Lineage Cell Therapeutics, NeoGenomics Laboratories, Ontopos, Partek Inc., PerkinElmer, Qiagen, Seven Bridges Genomics, Source BioScience, Thermo Fisher Scientific and Waters Corporation
In June 2024, Valeo Partners with Dassault Systemes to Accelerate the Digitalization of Its R&D. Valeo will deploy Dassault Systemes' 3DEXPERIENCE platform to optimize the development of new technologies for safer and more sustainable mobility
In May 2024, JLR and Dassault Systemes Extend Partnership, Deploying the 3DEXPERIENCE Platform for All Vehicle Programs Worldwide. The 3DEXPERIENCE platform connects all stakeholders in one collaborative virtual environment, leveraging the latest technological innovation
In March 2024, Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024. The new mass spectrometry and chromatography instruments and software solutions enable customers to unlock deeper analytical insights with built-for-purpose flexibility
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.